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Prader-Willi and Angelman syndromes (PWS and AS) typically result from an ∼4-Mb deletion of human chromosome
15q11-q13, with clustered breakpoints (BP) at either of two proximal sites (BP1 and BP2) and one distal site (BP3).
HERC2 and other duplicons map to these BP regions, with the 2-Mb PWS/AS imprinted domain just distal of
BP2. Previously, the presence of genes and their imprinted status have not been examined between BP1 and BP2.
Here, we identify two known (CYFIP1 and GCP5) and two novel (NIPA1 and NIPA2) genes in this region in
human and their orthologs in mouse chromosome 7C. These genes are expressed from a broad range of tissues
and are nonimprinted, as they are expressed in cells derived from normal individuals, patients with PWS or AS,
and the corresponding mouse models. However, replication-timing studies in the mouse reveal that they are located
in a genomic domain showing asynchronous replication, a feature typically ascribed to monoallelically expressed
loci. The novel genes NIPA1 and NIPA2 each encode putative polypeptides with nine transmembrane domains,
suggesting function as receptors or as transporters. Phylogenetic analyses show that NIPA1 and NIPA2 are highly
conserved in vertebrate species, with ancestral members in invertebrates and plants. Intriguingly, evolutionary studies
show conservation of the four-gene cassette between BP1 and BP2 in human, including NIPA1/2, CYFIP1, and
GCP5, and proximity to the Herc2 gene in both mouse and Fugu. These observations support a model in which
duplications of the HERC2 gene at BP3 in primates first flanked the four-gene cassette, with subsequent transposition
of these four unique genes by a HERC2 duplicon-mediated process to form the BP1–BP2 region. Duplicons therefore
appear to mediate genomic fluidity in both disease and evolutionary processes.
Introduction
Prader-Willi syndrome (PWS [MIM 176270]) and Angel-
man syndrome (AS [MIM 105830]) are imprinted ge-
netic disorders that arise most commonly from an ∼4-Mb
deletion of human chromosome 15q11-q13 (Nicholls and
Knepper 2001). Molecularly, there are two common
classes of deletions in patients with PWS/AS, one from
breakpoint (BP) 1 to BP3 and the other from BP2 to
BP3 (Knoll et al. 1990; Amos-Landgraf et al. 1999;
Christian et al. 1999) (fig. 1a). PWS arises from the
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functional loss of a set of paternally expressed genes,
whereas AS is associated with the loss of maternally
expressed genes. Within a 2-Mb imprinted domain distal
to BP2, five paternally expressed genes encoding poly-
peptides have been identified; the genes include MKRN3
(Jong et al. 1999), NDN (Jay et al. 1997; MacDonald
and Wevrick 1997), MAGEL2 (Boccaccio et al. 1999;
Lee et al. 2000), and the polycistronic SNURF-SNRPN
(Gray et al. 1999). This last locus also encodes five clas-
ses of snoRNAs (Cavaille´ et al. 2000; de los Santos et
al. 2000; Runte et al. 2001). Adjacent to the telomeric
end of the paternally expressed domain are two mater-
nally expressed genes, with loss of function of UBE3A
underlying the neurological phenotype of AS (Jiang et
al. 1998; Nicholls and Knepper 2001) and loss of the
imprinted ATP10C locus (Herzing et al. 2001; Meguro
et al. 2001) putatively associated with obesity in AS
(Dhar et al. 2000; Lossie et al. 2001; Nicholls and Knep-
per 2001). Genes in 15q11-q13 are homologous to
mouse chromosome 7C (fig. 1a), with the exception
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of the paternally expressed Frat3 gene, a recent evolu-
tionary acquisition in the mouse (Chai et al. 2001).
These imprinted loci in human and mouse are controlled
in cis by a centrally located imprinting center (IC), a
complex genetic element that acts bidirectionally over
distances of at least 0.5–1.0 Mb to establish and/or
maintain the maternal and paternal imprint (reviewed
by Nicholls and Knepper 2001).
In addition to imprinted genes, several nonimprinted
genes have been identified in the human and mouse
PWS/AS region (fig. 1a). These genes may be responsible
for other genetic disorders, and some of them may mod-
ify the PWS or AS phenotype. An example is the pink-
eyed dilution (p) gene on mouse chromosome 7C and
the corresponding oculocutaneous albinism type II
(OCA2) locus in human. Although OCA2 is recessive
in humans and mice, hypopigmentation is a frequent
finding in PWS and AS patients with the common de-
letion (Spritz et al. 1997; Nicholls and Knepper 2001).
Other recessive disease loci identified within the mouse
region homologous to PWS/AS are neonatally lethal
cleft palate (cp1) due to loss of Gabrb3 (Culiat et al.
1995; Homanics et al. 1997; Hagiwara et al. 2003) and
juvenile development and fertility (jdf2) associated with
Herc2 gene mutations (Lehman et al. 1998; Ji et al.
1999; Walkowicz et al. 1999).
Nevertheless, the complete extent of the imprinted
domain is not known in human 15q11-q13 or mouse
7C. The telomeric boundary of the 15q11-q13 im-
printed domain—and corresponding region in the
mouse—may be between ATP10C and GABRB3, since
genetic evidence in both species indicates that the latter
is not imprinted (Nicholls et al. 1993; Culiat et al. 1995;
Homanics et al. 1997; Nicholls 1999; Nicholls and
Knepper 2001). At the other end of the imprinted do-
main in humans, it has not been clear whether func-
tional genes occur centromeric of MKRN3, but Ritchie
et al. (1998) proposed that the imprinted domain might
extend significantly farther by identifying asynchronous
DNA replication at a partial duplication of the GA-
BRA5 locus, which maps proximal to deletion break-
points BP1 and BP2 in the pericentromeric region of
15q11.1. Replication asynchrony is a feature of im-
printed domains (Kitsberg et al. 1993; Knoll et al. 1994;
Simon et al. 1999) and other domains with monoallelic
gene expression (Chess et al. 1994; Hollander et al.
1998; Mostoslavsky et al. 2001). To define the extent
of this imprinted domain, we searched for novel genes
centromeric of MKRN3 and describe here four unique
genes in 15q11.2, the imprinting status of which was
tested in human and mouse. These genes include the
novel NIPA1 (nonimprinted in Prader-Willi/Angelman
syndrome 1) and NIPA2 genes (symbols approved by
the gene nomenclature committee), which encode highly
conserved polypeptides with possible function as recep-
tors or transporters. Both genes—as well as the flanking
CYFIP1 (Kobayashi et al. 1998; Schenck et al. 2001)
and GCP5 (Murphy et al. 2001) genes—are candidate
modulators of the PWS/AS phenotypes and/or may play
a role in other disorders mapping to this region in hu-
mans and mice. Furthermore, our phylogenetic studies
have identified an evolutionary transposition of these
four genes from the BP3 region of ancestral vertebrates
to form the human BP1–BP2 region. We propose that
this transposition was mediated by the flanking HERC2
and/or other duplicated sequences.
Material and Methods
Isolation of BAC Clones and STS Mapping of BAC and
YAC Clones
The CYFIP1 (SRA1) gene was identified by an in silico
search of National Center for Biotechnology Informa-
tion (NCBI) GeneMap ‘98. Of all EST clusters found in
proximal 15q, the cluster containing the 4.4-kb cDNA
KIAA0068 was the most robust, with numerous ESTs
in different tissues, and was subsequently identified as
SRA1/CYFIP1 (Kobayashi et al. 1998; Schenck et al.
2001). GeneMap ’98 presented compiled mapping data
from two radiation hybrid panels, GB4 and G3; how-
ever, because the relative order of markers was not con-
sistent between these panels, genes were further mapped,
by PCR, to BAC and YAC contigs (see below). CITD
BAC 3242E18 was identified by a BLAST search of the
GenBank Genome Survey Sequence (GSS) database us-
ing CYFIP1 cDNA sequence (GenBank accession num-
ber D38549). Exons 7 and 8 are present in the 3242E18
end sequence (AQ203319) in a 5′r3′ orientation com-
pared with the end sequence. Similarly, partially se-
quenced BAC clones RP11-26F2 (GenBank accession
number AC011767) and RP11-289D12 (GenBank ac-
cession number AC090764) were identified by BLAST
with CYFIP1 cDNA sequence and STS markers (Chris-
tian et al. 1999) D15S18, located in CYFIP1 intron 1
close to exon 2, and microsatellite markers D15S1035,
D15S541, and D15S542 that are clustered within CY-
FIP1 intron 1 ∼15 kb from exon 1.
For murine Cyfip1, which was originally identified as
Shyc (Ko¨ster et al. 1998), primers RN1102 and RN1103
were used to screen a Genome Systems mouse BAC li-
brary (129/Sv) by PCR, using 35 cycles at 94C for 2
min, 55C for 30 s, and 72C for 1 min, with a 10-min
final extension at 72C. Mouse RPCI-22 BAC 252P22,
which was identified by the PCR screen, was end se-
quenced, allowing a PCR product (amplified by RN1235
and RN1236) from one end of this BAC to be used to
further screen the RPCI-22 BAC library by hybridiza-
tion. This approach identified BACs 508F17, 402D17,
373J21, and 526E9, and BACs 466F3 and 304H15 were
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Figure 1 Genetic and physical maps. a, Schematic maps of human chromosome 15q11-q13 and the homologous mouse chromosome 7C
region. PWS/AS deletion BP hotspots 1–3 associated with HERC2 duplicons (dup) are shown, and the regions studied in the present work are
boxed and shaded. Two BAC clones spanning the four novel BP1–BP2 genes are indicated. Black and dark gray circles represent paternally and
maternally expressed imprinted genes, respectively, and white circles are biallelic, nonimprinted genes (the mouse Atp10c gene is likely, but not
proven, to be maternally expressed [light gray circle]). Genes or regions associated with PWS, AS, oculocutaneous albinism type II (OCA2),
and a transgene insertion-deletion mouse model of PWS/AS [TgPWS/AS(del)] are indicated. b, PCR mapping of NIPA1 and GCP5 STS markers
within YACs spanning the BP1–BP2 region. c, PCR detection of a CYFIP1 STS marker in BP1–BP2 YACs. d, Orientation of BP1–BP2 genes,
with detailed map of YACs and STS markers spanning BP1–BP2. Markers from this study are shown by large black circles, and data for the
HERC2-dup CpG island probe (black squares, HindIII fragment sizes in kb also shown) and 254RL2 probe (gray squares) are from Amos-
Landgraf et al. (1999). The left (L) and right (R) YAC ends (Ye), and deleted fragment (?) are also shown. e, Schematic of class I and II PWS
and AS deletions, with detection by FISH using unique BAC clones spanning CYFIP1. f, Fine mapping and BAC contig of six nonimprinted
genes in mouse 7C. Each gene is shown proportionally by the length of black arrows, with direction of transcription from 5′ to 3′. The map
was determined by STS analysis derived from exons (e) and BAC ends in a series of BACs and mouse 10-kb clones (thin black bars under
genes). Black and white squares represent STSs confirmed by PCR assay or identified by database DNA sequence analysis without further PCR
assay, respectively.
identified with a PCR probe from the 195C6 T7 BAC
end (table 1). BLAST searches of GSS, with the use of
cDNA sequences of Cyfip1, Nipa1, Gcp5, Herc2, and
p, were conducted, identifying BACs RPCI-23 (C57BL/
6) 88I18, 452K16, 363F10, 471F18, 335K21, 49E2,
195C6, 396N13, 256L9, and 181P23 and RPCI-24
247O4, 150F2, 354P8, and 265E12. DNA from all
BACs was isolated according to the minipreparation
protocol recommended by Research Genetics. To estab-
lish BAC contigs and to determine gene order for the
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mouse loci, several pairs of primers were designed from
gene exons or BAC ends (table 1). PCR was conducted
under conditions of 94C for 2 min, 31 cycles of 94C
for 30 s, 60C for 30 s, and 72C for 30 s and a 10-
min final extension at 72C.
DNA from YAC clones spanning the BP1–BP2 region
was isolated as described elsewhere (Amos-Landgraf et
al. 1999). STS primers from single exons of the NIPA1,
GCP5, and CYFIP1 genes (table 1) were used for PCR
typing of these YACs, using 10 ng DNA for each PCR.
PCR used the following cycling conditions: 94C for 2
min, then 35 cycles of 94C for 30 s, 55C for 30 s,
72C for 30 s, and a final extension for 10 min at 72C.
FISH
For human studies, metaphase chromosome prepa-
rations were made from lymphoblastoid cell lines de-
rived from class I and class II AS deletion patients (I:
WJK29, WJK43; II: WJK18, WJK35, WJK48; Knoll et
al. 1990), as well as normal individuals, according to
standard protocols. BAC 3242E18 was used as the probe
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Table 1
PCR Primers (5′r3′)
Position Forward Reverse
Cyfip1 3′ UTR (exon 31) RN1102 ACTGATGGCATGTTTGTCTTTATG RN1103 GCTCGTACAGATGAGTGATTTAGC
Cyfip1 exon 1 RN1389 GAGACTTGGGGAGACTTG RN1390 GACTACAGTGGAGCAAGGA
Cyfip1 exons 4–7 (cDNA) RN1023 CATGCTGTACACCTGGAGGA RN1024 GCCAGGAACATGGACAGATT
CYFIP1exons 17–25 (cDNA) RN1213 CAGCTGTGGTTCCGAGAGTT RN1214 TCAGCGTCTTCACGTACTGC
CYFIP13′ UTR RN1021 GCATGCCTTTCTCTCCGTAA RN1022 CCTTTCGATCTGATGTCACG
D7Mit70 RN1629 CACTTGGGGAACGTCAAGAC RN1630 TGTAGACCATAGCCCATAAGCC
Gcp5 3′ UTR (exon 23) RN1635 CCTGTCTAGACAATGGATTG RN1636 GTGGTCTACTTTTATACAACTC
Gcp5 5′ UTR (exon 1) RN1631 CATATGTTCCTGGTCTAATCAG RN1632 GAGAGTCTTCAGACAGCTAAC
GCP5 5′ UTR (exon 1) RN1803 GACAGGCACCAATTCGTTAG RN1804 GTTTAGGGCGAGCTGGAAG
GCP5 3′ UTR RN1611 CATGCCTCTAATCCCAGCAC RN1612 GCAAGTGGTTCTTTCTGAGTC
GCP5 exons 10–11 (cDNA) RN1609 AGCTGTTTACGATCTGTGCTG RN1610 CAGGGTGTTAAGCAGGTGAG
Herc2 exon 1 RN1575 GTCATTTGTCGTTGCGATAG RN1576 CTTCCAATAGAGGTAGAGTC
Herc2 exon 82 RN691 GCTCTCTTGATGAAACTGGACTCG RN693 ACAGGCCCATGTTGGCGATCTCG
Herc2 exon 93 RN1569 CTACTTGTGGGTGCAATAG RN792 GTCCACTAAAATGCCTCAAT
Mkrn1 (cDNA) RN1266 TGAGAGGCCTGCCTAGGAGAG RN1268 GCCTTGGAAAGTTGACTGCAGAG
Nipa1 exon 1 RN1432 GGCATGGGGACTGCGGCG RN1399 CTTCTGTAGCACGAACGTG
Nipa1 exon 3 RN1401 CTGTCGCCAGATTGGAAAC RN1402 GTACTCCAAGGGCACCTAG
NIPA1 exon 1 RN1651 CTCTTCCTGCTCCTCCCCCA RN1653 CACCTGCGACCGCCTTCTC
NIPA1 exons 2–4 (cDNA) RN1394 AACAGACATTGTGTGGTGGG RN1431 ATGTTGAGCTTTTCCTTCAG
NIPA2 exons 3–6 (cDNA) RN1384 GATTGGCTATGACCTCCAGCA RN1386 GGAGCATGAATGACCATAACTG
Nipa2 exon 7 RN1396 TTCAGTCTCCTGTGTGAAGG RN1397 ATCTGTGTGCTCACACAGAC
p exon 2 RN1566 CCGACTCTATAGTGAGAAACC RN1567 GCCAAACTCTGTATGTTCAGG
p exon 24 RN1585 CTGTGATGCTCATGTCCTGC RN1586 CCTGAACAAAGATTGGTTGC
RP22-252P22 SP6 RN1237 CCAAGAGCTAAAACTGGCAGA RN1238 CAGCAAACCTGATGGCAGTA
RP22-252P22 T7 RN1235 GCCCAGAGACAGGGAAAATTA RN1236 GCCCCACTGAGTCCTGTAGA
RP23-195C6 T7 (Herc2 intron 56) RN1511 CAATGTTGCTGCTAGCTCTG RN1512 GAGTGTCTTCTGTGGGTCAC
RP23-363F10 T7 RN1409 CCTCCATCAGAAGTCATTGC RN1410 GACTGAAATTGGATCCCTAG
RP24-265E12 T7 RN1613 GACAAGGTGATTAGGAGAGG RN1614 TGCTCAAGAGCAGAGCACTC
SNURF-SNRPN exons 2–3 (cDNA) RN420 ATCGCTTACACTTGAGAAGAACTA RN423 CTGCTTTAACCACCTCTTGGTGTC
Snurf-Snrpn exons 3–9 (cDNA) RN826 TCTCAGCAACAGCAAGTTCCTG RN639 GGTGGAGGGGGTCTCATTCC
for the human chromosome FISH studies. BAC DNA
was labeled with biotin or digoxigenin, by nick trans-
lation. Chromosomal hybridizations were detected as
described elsewhere (Knoll and Lichter 1994; Amos-
Landgraf et al. 1999). Ten to twenty metaphase cells
were analyzed per cell line. To identify the chromosomal
location of murine Cyfip1, BAC 252P22 was digoxi-
genin labeled and hybridized to murine metaphase chro-
mosomes derived from TgPWS(del) splenocytes, along with
a mouse chromosome 7 centromere probe (kindly pro-
vided by A. G. Matera), which also hybridizes to the
telomere of chromosome 5, labeled with biotin, as de-
scribed elsewhere (Gabriel et al. 1999). Probes were de-
tected by fluoroscein-labeled antidigoxigenin and Texas
red avidin, with DAPI (4′,6-diamino-2-phenylindole)
counterstaining.
DNA-replication–timing studies were performed as
described elsewhere (Greally et al. 1998). A mouse sple-
nocyte culture was pulsed with bromodeoxyuridine
(BrdU, 100 mM) 90 min prior to harvesting. The cells
were then harvested, fixed with methanol–acetic acid
and spread onto slides (Henegariu et al. 2001). The BAC
probes (452K16 and 252P22) were labeled by nick
translation using digoxigenin, Texas red, and biotin.
FISH was performed by denaturing the slides, using
0.05N NaOH at room temperature for 4 min, followed
by suppressive hybridization using probes preannealed
with mouse Cot-1 DNA. The haptens were detected us-
ing antidigoxigenin-rhodamine and avidin-CY5, while
simultaneously detecting S-phase cells with anti-BrdU-
FITC (Pharmingen), followed by counterstaining with
DAPI. Multiple image planes were acquired for each cell,
to ensure that all signals were identified. Replication pat-
terns in S-phase cells were assigned as prereplicative if
a single signal was seen at a locus and were assigned as
postreplicative if more than one signal was evident. The
replication patterns for 50 nuclei were analyzed for each
probe. For the parent of origin-specific patterns at the
Nipa1-Nipa2-Cyfip1 locus, simultaneous probing with
RPCI-22 BAC 434N7 was performed with a different
fluorophore on c32DSD mice with a Tyr deletion on their
paternal chromosome (Rinchik et al. 1993). The 434N7
signal from the maternal chromosome colocalized with
one of the Cyfip1 homologues in S-phase cells, allowing
the confident assignment of parental origin in 190% of
cells. The few cells in which the Tyr signal was not clearly
associated with one chromosome were not included in
our analyses.
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Identification of NIPA1 and NIPA2 cDNAs
BLAST search of the GenBank GSS database, using
Cyfip1 cDNA sequence (GenBank accession number
AF072697), matched sequence at one end of a mouse 10-
kb plasmid 1M0204M02F (GenBank accession number
AZ424789). The other end of this plasmid had a segment
99% identical to the Mus musculus hypothetical protein
MNCb-2146 (renamed Nipa2) mRNA (GenBank acces-
sion number NM_019997; 1,867-nt sequence), 85% to
several human cDNA clones (GenBank accession num-
bers HSU90904, BC011775, and BC000957), and 83%
to a Gallus gallus cDNA (GenBank accession number
AL588904) in the nonredundant GenBank database. A
full-length human NIPA2 cDNA (2,421 bp) spanning ex-
ons 1–7 was then assembled in silico on the basis of these
cDNAs and partial genomic sequences from BACs 26F2
and 289D12 (see above). The cDNA sequences included
one clone with exons 1 and 3–7 (2247-bp, BC011775),
and one 5′ clone with exons 1, 2, 2b, and 3 (GenBank
accession number BF203654). Exon 2b is a rare alter-
natively spliced exon in the 5′ UTR of human NIPA2, but
it is not conserved and is likely nonfunctional. Subsequent
BLAST searches confirmed numerous mouse and human
ESTs with the predominant structure including sequence
spanning seven exons. NIPA2 is oriented tail to tail with
CYFIP1, with 1,747 nt between the two genes. A Gallus
gallus Nipa2 cDNA clone (GenBank AL588904) from a
chicken brain library was obtained from the Roslin In-
stitute, United Kingdom, and was sequenced completely
through the DNA Sequence Facility at the University of
Pennsylvania School of Medicine. The 5′ end was from a
chicken EST (GenBank accession number AJ452290).
BLAST searches using human and mouse Nipa2 coding
sequence in the Fugu Project Database identified five ex-
ons spanning the conserved ORF sequence of Fugu Nipa2
(FT:T000059 Scaffold 59; these data were generously pro-
vided by the Fugu Genome Consortium for use in this
publication only).
Human NIPA1 was identified by in silico methods,
beginning with identification, within partial BAC 26F2
genome sequence, of a second strong CpG island not
associated with the 5′ end of NIPA2. This unique se-
quence matched with three human ESTs (GenBank ac-
cession numbers AW962805, AA355571, and D81972),
which identify an exon-intron structure by comparison
with BAC 26F2 sequence, suggesting the presence of a
unique gene that further analyses identified as NIPA1.
The AW962805 EST sequence covers part of exons 1–
4 of NIPA1, as well as an exon termed 3b. Exon 3b is
alternatively spliced (see below), but it has an in-frame
stop codon, is not present in other EST clones, occurs
at lower levels in RT-PCR products than does product
with exons 2–4 (see below), and is not conserved in the
mouse. These facts led us to conclude that exon 3b is
nonfunctional. BLAST search of the GenBank EST data-
base also identified an initial fourth human EST (Gen-
Bank accession number BE003132), which spans part
of exons 4 and 5 and the 3′ UTR of NIPA1, as well as
three putatively orthologous mouse ESTs (GenBank ac-
cession numbers BF118592, BE654018, and BF539166).
Genome sequence within BAC 26F2 that lay 3′ of the
NIPA1 ORF was then used, combined with BLAST
searches of the EST database, to identify numerous
cDNA clones containing the two 3′ ends of NIPA1 pre-
dicted on the basis of the mRNA size from northern
blots (2.2 and 7.5 kb) and the presence of a polyaden-
ylation signal and polyA tract at one end of the EST
sequences.
The mouse BF539166 cDNA clone was purchased
from Research Genetics and was sequenced to comple-
tion; it represents a full-length 1.9-kb mouse Nipa1
cDNA. Several mouse Nipa1 gene exon-intron boundary
sequences were initially predicted on the basis of se-
quences identified by BLAST search of the mmtrace da-
tabase and were subsequently confirmed by direct se-
quencing (data not shown) and by in silico analyses of
BAC and shotgun sequence from the public genome se-
quence, as well as Celera databases. BLAST search of
the Fugu Project Database with mouse NIPA1 amino
acid sequence identified all five exons for the ORF se-
quence of the orthologous Fugu Nipa1 (as above for
Nipa2).
Analyses of NIPA1 and NIPA2 Polypeptide Sequences
In addition to the NIPA1 and NIPA2 genes identified
as above for human, mouse, Fugu, and chicken (NIPA2
only), using translated BLAST searches of cDNA and
genome project databases, we identified an NIPA2 or-
tholog in Xenopus (encoding a putative polypeptide of
362 amino acids), as well as a single ancestral gene in
Drosophila (385 amino acids), Anopheles gambiae (351
amino acids), and Caenorhabditis elegans (358 amino
acids), and a representative paralog in Arabidopsis (343
amino acids). CLUSTAL W (Thompson et al. 1994) was
used to align NIPA1, NIPA2, and ancestral gene amino
acid sequences, with comparison of NIPA1/2 orthologs
and paralogs by an identity/similarity matrix program,
while phylogenetic analyses used drawtree to plot an
unrooted tree diagram. Putative transmembrane helices
were predicted based on hydrophobicity plots using the
TMHMM (v. 2.0) program. It may be noted that a WW
protein-protein interaction domain was predicted to oc-
cur in mouse and human NIPA1 proteins; however, we
assume this was a chance similarity, since it spans a
strong transmembrane (TM) helix (H) domain and is
not conserved.
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Determination of Gene Expression by RT-PCR
and Northern Blot Analyses
Total RNA samples were extracted using TRIzol (In-
vitrogen), according to the manufacturer’s protocol,
from lymphoblast cell lines derived from normal indi-
viduals, unaffected and affected patients with an im-
printing defect from the PWS-U (Buiting et al. 1995) and
AS-J families (Saitoh et al. 1996), and rodent-human
somatic cell hybrids with a single maternal (20L-28) or
paternal (A59-3az) human chromosome 15 (Gabriel et
al. 1998). For the hybrids analysis, PCR primers were
human specific. In addition, RNA was extracted from
homogenized mouse brain from three genotypes of mice:
wild-type, transgenic PWS, and AS (TgPWS(del) and
TgAS(del)), the last two of which have an ∼4-Mb deletion
of mouse chromosome 7C (Gabriel et al. 1999). From
each sample, 1–10 mg of total RNA was pretreated with
DNase I (GIBCO-BRL), with half of this used to syn-
thesize first-strand cDNA, using SuperscriptII reverse
transcriptase (GIBCO BRL) and an oligo dT primer plus
random hexamers (RT), and the other half was reverse
transcriptase free (RT). One twenty-fifth of each re-
action was used subsequently for PCR amplification,
with 10 mM Tris-HCl (pH 8.4), 50 mM KCl, 2 mM
MgCl2, 0.2 mM dNTPs, 2 U Taq DNA polymerase
(GIBCO BRL), and 200 nM each of primers, in a 25-ml
reaction volume. To assess imprinting, we utilized 35
cycles of 94C for 2 min, 55C–60C for 30 s, and 72C
for 1 min, with a 10-min final extension at 72C. Primers
used for each locus (table 1) were as follows: human
and mouse NIPA1 exons 2–4; human and mouse NIPA2
exons 3–6; human and mouse GCP5 exons 10 and 11;
human CYFIP1 3′ UTR, as well as exons 17–25; mouse
Cyfip1 exons 4–7; human SNURF-SNRPN exons 2 and
3; mouse Snurf-Snrpn exons 3–9; and mouse Mkrn1.
RT-PCR products obtained from human and mouse
NIPA1 (167 bp), NIPA2 (339 bp), and GCP5 (399 bp),
human CYFIP1 3′ UTR (505 bp), and mouse Cyfip1
3′ UTR (258 bp, RN1102, and RN1103), as described
above, were subcloned into a TA vector and used for
preparation of probes. The probe for SNURF-SNRPN
was similarly prepared from TA-cloned PCR product of
exons 2 and 3 by amplification with RN420 and RN423.
Probes were labeled with a-32P-dCTP and were hybrid-
ized to human multiple tissue and brain multiple tissue
northern blots (Clontech), human 12-lane MTN blot
(BD Biosciences), or mouse multiple tissue northern blot-
2 (Sigma), according to the manufacturer’s protocol. b-
ACTIN or SNURF-SNRPN and Gapdh were used as
controls for human and mouse northern blots, respec-
tively. Hybridizations were performed using ExpressHyb
(Clontech) at 65C and were washed at high stringency
in 0.1# SSC  0.1% SDS at 60C–65C. Membranes
were exposed to autoradiographic film at 80C.
Results
Identification and Fine Mapping of Novel Genes in the
BP1–BP2 Region of Human 15q11.2
To identify novel genes in the BP1–BP2 region, we
first used BLAST searches with the chromosome
15q11.2 STS marker D15S18 and microsatellite markers
D15S1035, D15S541, and D15S542 (Christian et al.
1999) to identify partially sequenced (subsequently com-
pleted) BACs RP11-26F2 and RP11-289D12, which span
this region (fig. 1a). From GeneMap ’98, we identified
the KIAA0068 EST, subsequently recognized as SRA1/
CYFIP1 (Kobayashi et al. 1998; Schenck et al. 2001),
with exons in each of the two BP1–BP2 region BACs, a
location confirmed by PCR (see below). Subsequently,
we identified a second gene, GCP5 (Murphy et al. 2001),
adjacent to CYFIP1, by BLAST searches with genomic
sequence from BAC 289D12. Gene structures for these
two genes have not been previously determined. The
human CYFIP1 gene spans 111.4 kb and has 31 exons
(table 2) overlapping BACs 26F2 (exons 23–31) and
289D12 (exons 1–24) (fig. 1a), with short 5′ and 3′ UTRs
of 52 nt and 562 nt, respectively. Exon 1 is noncoding,
with the AUG start codon present at the 5′ end of exon
2. Mouse Cyfip1 has a similar 31-exon gene structure.
Human GCP5 (also known as TUBGCP5) spans 46.8
kb and 23 exons with a 54-nt 5′ UTR and a 643-nt 3′
UTR (table 3), with a similar structure in the mouse
(data not shown). Although 45% of the human GCP5
3′ UTR and 17% of the mouse 583-nt 3′ UTR are an
Alu and a truncated B2 repetitive element, respectively,
these short interspersed nuclear elements (SINEs) have
different evolutionary origins and are inserted at differ-
ent positions and orientations, which suggests coinci-
dental insertion and a lack of selection on the 3′ UTR
in each species. The CYFIP1 and GCP5 genes are ar-
ranged in a head-to-tail orientation in human and mouse
(fig. 1a), with the 5′ ends of both genes associated with
strong CpG islands. In addition, two novel CpG island
sequences not associated with either known gene were
identified from genomic sequence of BAC RP11-26F2,
and these are characterized in detail below as being lo-
cated at the 5′ ends of the NIPA1 and NIPA2 genes.
Because of the repeated nature of HERC2- and other
duplicons in BP1 and BP2 and because of poor BAC and
DNA sequence coverage in these regions, such analyses
could not determine the orientation of BACs 26F2 and
289D12 or of the four BP1–BP2 region genes with re-
spect to the centromere. Using primers derived from the
5′ end of NIPA1 (fig. 1b), both 5′ and 3′ ends of GCP5
(fig. 1b) and the 3′ UTR (exon 31) of the CYFIP1 gene
(fig. 1c), we performed PCR on a panel of YACs known
to span the BP1–BP2 region (fig. 1d). This YAC panel
was characterized previously by STS content and
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Table 2
Exon-Intron Structure of the Human CYFIP1 Gene
Exon
cDNA Position
(bp)
Splice Acceptor
Intron Exona
Exon Size
(bp)
Splice Donor
Exon Introna
Intron Size
(bp)
1 1–46 5′ UTR 46 GCGGACGCAGgtgaggaacc 32,993
2 47–169 tatgtgttgttccagCCCAGGATGG 123 GCTCTACCAGgtgggtgccc 74
3 170–259 cttcctttccttcagCCAAATTTCA 90 CTCTAGCATGgtaatgttgc 2,062
4 260–337 tgtgttccattgcagAACGAGATGC 78 CATCCCACAGgtgccacgct 197
5 338–439 ttcctttattcccagGTGAAATGTA 102 GTACTTCCAGgtaaaatggc 1,198
6 440–621 gcttcctctgcacagAGAAATGCCA 182 CGTACAAGAGgtgagcaccc 3,660
7 622–718 tttttgttttcaaagGGCCGCTCAG 97 GATCACACAGgtaaggctgg 85
8 719–847 tgctctgtgtttcagTCTCTGCAGC 129 GCTTCTCAAAgtacgtgtgt 1,979
9 848–952 tttgtggcttttcagGTCATGGGAT 105 GTACTTCAAGgtgagttaca 3,212
10 953–1,044 gttctttgaatacagCAACTCCAGG 92 ATAAATCTCGgtaggaggag 1,460
11 1,045–1,162 tttctctctgcacagATGGACGTGC 118 CAACAGCGAGgtcgccccgc 4,185
12 1,163–1,285 gcccgccttgtgcagGTGGTCACGG 123 GATGGAAGTGgtaggccccg 1,797
13 1,286–1,411 tttcggccaccacagTATTCCTGGA 126 CCTAGTGGAGgtgaggatgc 7,115
14 1,412–1,578 ctgtgtcccccgcagGTGATCGCCA 167 TCATCCAGAGgtcagccttc 753
15 1,579–1,726 tggtggggtgttcagTGTCCTGCAG 148 CAGCACTCAGgttctcgtcc 1,152
16 1,727–1,880 ccttggataatccagCTTTACATGG 154 AATTTCAGTGgtaagagata 1,593
17 1,881–2,037 tttgaaccctcccagAAACGCTGCA 157 CGATGATGGAgtgcgtgtcc 2,437
18 2,038–2,134 tgctgtcctctgcagGTACGTGCTC 97 TGAGGCCGAGgtgaggcccc 1,354
19 2,135–2,211 tttctttttcttcagGTGAATCTAT 77 TGGCAGGAAGgtgagtatct 105
20 2,212–2,320 ttccttctacactagTTTGCTTCTT 109 GCATGTGCAGgtgagctggg 1,201
21 2,321–2,440 ccctgtgtacgccagCTCCTCGGCA 120 CTCCATAGTTgtaagtaatt 5,287
22 2,441–2,640 tctttggtgccacagGAGCTGGATG 200 CTACCAACCGgtgagcgtgc 10,723
23 2,641–2,728 atctttcttgtttagGTTTGTTCGG 88 TGGATCCAAGgtaggctcca 9,878
24 2,729–2,872 tgccctgttttccagGCTTTGAACT 144 CAAGAGCCTGgtgagtgttc 932
25 2,873–2,963 tcatctccccggcagCTGCAAGGCA 91 GGCTCTCCTGgtgagtgcgg 1,703
26 2,964–3,094 ctcccgccaccgtagGTATCCTGGA 131 GCAGAGCCTGgtgagtggcc 4,642
27 3,095–3,167 ctttctctgctctagTCTTTAGAAG 73 CATGTGAAAGgtgagcctgc 475
28 3,168–3,262 ttttttctactgcagAGGGGGAGAG 95 GACCCCTCAGgtaacgtgta 821
29 3,263–3,501 ttgtcctttctgcagCAAATTGCCA 239 TCACAGTCGAgtaagtgtgt 1,340
30 3,502–3,649 gcttcttgttcctagGCAGTGCTTT 148 TAAAAATGTGgtatgtggat 2,633
31 3,650–4,376 ctttgatggttgtagCCTTTGAAGA 727 3 UTR (3818–4379) NAb
a Lowercase letters refer to intron sequences, and uppercase letters refer to exon sequences. Underlined letters “ag” and “gt” represent
consensus splice acceptor and donor sequences, respectively. The underlined “AGT” represents the sequence coding for the translation initiation
codon in the corresponding mRNA.
b NA p not applicable.
HERC2-duplicon mapping (Amos-Landgraf et al. 1999).
Both NIPA1 exon 1 and the 3′ UTR of CYFIP1 were
detected on YACs 931C4 and A124A3 (fig. 1b, c, and
d), confirming that these genes map proximal to BP2 of
MKRN3 and were therefore proximal to the known
PWS imprinted domain. Furthermore, both ends of
GCP5 are within YAC 931C4 but not A124A3 or any
BP2 region YACs (fig. 1b and 1d), unambiguously de-
fining the order as cen–NIPA1–CYFIP1–3′-GCP5-5′–
BP2–tel.
FISH Mapping of BP1- and BP2-Associated
Rearrangements
BAC clone 3242E18, containing exons 7–31 of CY-
FIP1 from the BP1–BP2 region (fig. 1e), was utilized for
FISH studies on metaphase chromosomes from three
normal human lymphoblastoid cell lines, with hybridi-
zation to a single region of proximal chromosome 15 in
band 15q11.2 (fig. 2a). No other chromosomal hybrid-
izations were detected, including in interphase cells, con-
firming that BAC 3242E18 does not contain duplicon
sequences. Therefore, we investigated the pattern of hy-
bridization of BAC 3242E18 against a panel of cell lines
from patients with AS deletions. Deletions in patients
with AS and PWS (fig. 1e) are either class I, which ex-
tends from BP1 (15q11.2) to BP3 (15q13), or class II,
which extends from BP2 (15q11.2) to BP3 (Knoll et al.
1990; Amos-Landgraf et al. 1999). As expected, the
3242E18 FISH assay distinguishes class I and class II
deletions in patients with AS, because the BAC is present
on both chromosomes 15 in cells of three class II patients
and is present only on the normal chromosome 15 in
cells from two class I patients (fig. 1e; data not shown).
Physical Map Spanning Six Genes at the Centromeric
End of Mouse Chromosome 7C
The human CYFIP1 gene is orthologous to the mouse
Shyc (Cyfip1) gene (Ko¨ster et al. 1998; Schenck et al.
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Table 3
Exon-Intron Structure of the Human GCP5 Gene
Exon
cDNA Position
(bp)
Splice Acceptor
Intron Exona
Exon Size
(bp)
Splice Donor
Exon Introna
Intron Size
(bp)
1 1–200 5′UTR (1-54) 200 CCAACTTCAGgtgtggggcacg 2,244
2 201–254 tgtctttaatagATTTCATCGT 54 CAATCGAAGGgtatgccttcaa 92
3 255–363 cttatattttagAATTTATGAA 109 GGAAATAAAGgtatgccttcaa 4,075
4 364–460 tttgttttaaagACAGATGCAC 97 AAAGAAGTGGgtatgttactag 696
5 461–540 gttacattttagAAAAGAAAGA 80 GGACACACCAgtaagtggtagt 928
6 541–675 tttttaaatcagAATTGGTCTG 135 AGTTGGAAAGgtattatgtgtt 3,582
7 667–791 cagatgagccagATGAGCCAGA 125 CTGCTGTCTGgtaagaagctaa 985
8 792–881 gctgtctcatagGGACCAACAC 90 AAACCCTATGgtaagaaatgtt 1,284
9 882–975 atctcatttcagGTTACTTTCA 94 TTTAACACATgtaagttatttg 542
10 976–1,222 cttgtgttgtagAGCTGTTTAC 247 ATCAATAATGgtattaaatgtt 1,784
11 1,223–1,425 tgatatttgcagATACTACAAT 203 TGAGCAAACCgtaagtgagact 2,623
12 1,426–1,539 tctctgcctcagGTCTCCCTCC 114 TCATCCAGAGgtgagctgcagc 7,177
13 1,540–1,809 gaatctctttagAAACAAAAAT 270 GGAGCCAGAGgtacttgttccg 6,824
14 1,810–2,009 tttatgtttcagATGCAGAAAG 200 ACTTTGCAAGgtgagacacacc 998
15 2,010–2,198 ttttatcttgagGATGTATTTG 189 AAGATTACAGgtaaaagagtaa 1,063
16 2,199–2,381 ctctccattcagGTTGGTAGAA 183 ATAGTTCACAgtaaaatatgga 2,348
17 2,382–2,466 ttctttctttagTCTATCTATA 85 CAGCTACAAGgtatatgctgat 94
18 2,467–2,587 tttgtttcatagGTCCCATGGC 121 CTTTTTGGTGgtaagatttgtt 440
19 2,588–2,766 aatgttttatagAACTGGTTAG 179 CATGACCAGGgtttgtgcctct 1,203
20 2,767–2,892 ttctcttccaagATTCTACACA 126 GAGAGAAAAGgtacatgagatg 947
21 2,893–2,981 tttggtctgcagGTCAGCTTTG 89 GCACTTGGCGgtaagtatgtga 2,394
22 2,982–3,082 ttttattcctagAATGGAATCT 101 TTTCCCCATTgtgagtatatca 701
23 3,083–3,771 ttcttcccacagTGGAATCTCT 689 3′ UTR (3127–3771) NAb
a Lowercase letters refer to intron sequences, and uppercase letters refer to exon sequences. Underlined letters “ag”
and “gt” represent consensus splice acceptor and donor sequences, respectively.
b NA p not applicable.
2001). We isolated the Cyfip1 129/Sv RPCI-22 252P22
BAC clone (fig. 1f) by PCR screening with a 3′ UTR STS.
FISH was then performed on metaphase chromosomes
from a mouse model of PWS with a chromosome 7C
deletion (Gabriel et al. 1999). BAC 252P22 (Cyfip1)
localizes to the normal chromosome 7C region and
within the mouse transgene-induced deletion (fig. 2b),
which expands the known syntenic relationship between
human 15q11-q13 and mouse 7C (fig. 1a).
To generate a physical map, seven unsequenced 129/
Sv and 14 partially sequenced C57BL/6 BACs were iden-
tified (see “Material and Methods” section) and typed
by PCR with STSs derived from the p, Herc2, Nipa1,
Nipa2, Cyfip1, and Gcp5 genes and with BAC end se-
quences created in this study, allowing generation of an
overlapping BAC contig map (fig. 1f). These data indi-
cate that the genes in this region are arranged in the
order cen–Gcp5–Cyfip1–Nipa2–Nipa1–Herc2-p–tel (fig.
1f). The map is anchored at one end by an STS marker,
D7Mit70, which maps close to the l71Rl locus involved
in peri-implantation survival (Wu et al. 2000), that is
∼22 kb centromeric to Gcp5.
Replication Analyses of the Nipa1-Nipa2-Cyfip1 Locus
Replication-timing studies of imprinted regions have
demonstrated a parent-of-origin–dependent asynchrony,
using FISH and quantitative PCR techniques (Kitsberg
et al. 1993; Knoll et al. 1994; Simon et al. 1999). For
two BACs of different sizes that collectively span the
Nipa1, Nipa2, and Cyfip1 genes, we see a pattern of
asynchrony that is similar to that at the imprinted Mkrn3
and Snurf-Snrpn loci (fig. 2c). To test whether the pattern
at Nipa1-Nipa2-Cyfip1 was determined by parent of or-
igin, we used mice heterozygous for a deletion at the
mouse Tyr (c) locus (c32DSD) (Rinchik et al. 1993) to ex-
amine which chromosome was replicating earlier in each
cell. The relatively close linkage of Tyr to the imprinted
7C region (∼14 cM) makes this a useful marker for in
situ studies of this region while being sufficiently distant
that the likelihood that cis effects of the deletion cause
disruption of imprinting is very small. We found a pat-
tern of replication in these cells that was asynchronous
but was not due to parent-of-origin influences. In other
words, the proportion of cells that showed the paternal
chromosome replicating early was equal to the propor-
tion that showed the maternal chromosome replicating
early (fig. 2c).
Characterization of the NIPA1 Gene in Vertebrates
Human NIPA1 maps within BAC 26F2 and was iden-
tified, on the basis of a strong CpG island, by visual
inspection of genomic DNA sequence, followed by
Figure 2 FISH mapping of CYFIP1 in human and mouse, as well as DNA replication-timing asynchrony at the mouse Nipa1-Nipa2-
Cyfip1 locus. a, BAC 3242E18 spanning CYFIP1 (fig. 1e) is unique and maps to human chromosome 15q11.2 (arrows). b, BAC 252P22 (fig.
1f) maps to mouse chromosome 7C (green signal, yellow arrow) in metaphase chromosomes from TgPWS(del) mice. A control probe identifies the
chromosome 7 centromere (red signal, white arrow) but also hybridizes to the telomere of chromosome 5 (white arrowhead). c, Probes from
imprinted (BACs RP-23 371M8 and 266F22 for Snurf-Snrpn and Mkrn3, respectively) and nonimprinted (BACs 452K16 and 252P22 for Nipa1-
Nipa2-Cyfip1; see fig. 1f and fig. 5) loci exhibit asynchronous replication (a high singlet/doublet [1/2] proportion of hybridization foci in S-
phase cells, comparable to prior studies [Kitsberg et al. 1993; Greally et al. 1998; Simon et al. 1999]).
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assembly of a cDNA sequence contig, using BLAST
searches extending 3′ from the CpG island (see “Material
and Methods” section for details). This led to an NIPA1
cDNA sequence of 2,247-bp that spanned five exons and
38.8 kb in genomic DNA (fig. 3a) and encoded a putative
polypeptide of 329 amino acids (fig. 4a; see below). The
five NIPA1 exon-intron boundaries conform to consen-
sus splice acceptor and donor sequences (table 4), with
the translational AUG start codon present in exon 1, the
stop (TGA) codon in exon 5, and in the 3′ UTR an
ATTAAA variant polyadenylation signal at cDNA po-
sition 2221–2226 (fig. 3a; table 4). Although single base
changes of the hexanucleotide (AATAAA) poly(A) signal
sequence greatly reduce polyadenylation, the ArT sub-
stitution at position 2 of the noncanonical ATTAAA
hexamer is the mildest mutation and corresponds to the
most common variant (Sheets et al. 1990). Nevertheless,
multiple NIPA1 ESTs have polyA tails beginning 13–17
nt 3′ of this polyA signal, suggesting this as a bona fide
3′ end of low-abundance NIPA1 transcripts, which was
supported by northern analysis of gene expression, al-
though these studies also identify a larger neuronal tran-
script (see below). Therefore, we examined genomic se-
quence further 3′ both visually and by BLAST against
the EST database, which allowed identification of the
major human NIPA1 3′ UTR polyadenylation signal
(AATAAA) at cDNA positions 6540–6545. The latter is
embedded in a region that is highly conserved in five
eutherian mammals and that is diagnostic for the NIPA1
3′ end (fig. 3b).
Within the GC-rich (75%) exon 1 of NIPA1, we iden-
tified a (GCG)n repeat, encoding polyalanine (fig. 4a),
which we examined for polymorphism by one or both
of following methods: direct sequencing of exon 1 PCR
products or detection of PCR products by use of a 32P–
dCTP labeled primer. This analysis showed polymor-
phism in 135 chromosomes of European and Asian or-
igin with the number of repeats ranging from 6 to 10
(data not shown). The two most frequent alleles, (GCG)8
and (GCG)7, have allele frequencies of 0.78 and 0.2,
respectively. Additional studies are needed to determine
whether expansions occur in the NIPA1 (GCG)n repeat
and are disease associated.
The mouse Nipa1 cDNA was identified by in silico
methods, using the human coding sequence as well as
sequencing of a 1.9-kb cDNA clone. By comparison with
mouse genome sequence, the Nipa1 locus was found to
span 41.1 kb of genomic DNA and to include five exons
that are highly conserved with the human NIPA1 gene
(fig. 3a; table 4). Mouse Nipa1 encodes a putative poly-
peptide of 323 amino acids (fig. 4a), with an N-terminal
polyalanine sequence encoded by a (GCG)3 GCT(GCG)3
sequence in exon 1. In a manner similar to that in hu-
mans, two polyadenylation signals occur in the mouse
Nipa1 3′ UTR at cDNA positions 1866 nt and 6840 nt
of the cDNA (fig. 3a), both of which are AATAAA sig-
nals and correspond to the two Nipa1 transcripts (see
below). We also identified in silico the complete or-
thologous Nipa1 gene from the Fugu Project Database
by translated BLAST analyses, using human and mouse
amino acid sequences. This allowed us to predict a vir-
tual cDNA sequence of 932 bp, with five exons of similar
sizes and conserved consensus splice acceptor and donor
sequences, as for the human and mouse orthologous
genes (fig. 3a; table 4), and encoding a putative poly-
peptide of 304 amino acids (fig. 4a). As expected, the
genomic locus of Fugu Nipa1 is much smaller than that
of mammalian NIPA1 loci and spans only ∼1.4 kb, not
including the UTRs.
Characterization of the NIPA2 Gene
As with NIPA1, the human NIPA2 gene was identified
by in silico methods using BLAST of BAC 26F2 genomic
sequence, as well as identification of a second CpG island
in this BAC that represents the 5′ end of NIPA2. We
compiled a synthetic NIPA2 cDNA sequence of 2,450
bp, with an AATAAA poly(A) signal at positions 2444–
2449 utilized for polyadenylation (fig. 3c). NIPA2 spans
29 kb in the human genome and has seven exons (fig.
3c), each with consensus exon-intron boundaries (table
4), and for which exons 3–7 encode a NIPA2 putative
polypeptide of 360 amino acids (fig. 4b). The mouse
Nipa2 cDNA (see the “Material and Methods” section)
is very similar to human NIPA2, having seven conserved
exons (fig. 3c; table 4), encoding a putative polypeptide
of 359 amino acids in exons 3–7 (fig. 4b), and with this
locus spanning 29.8 kb in the mouse genome. Two forms
of the mouse Nipa2 cDNA (1,867 bp and 3,200 bp; fig.
3c) differ in the positions of alternative polyadenylation
sites in the 3′ UTR, created through the use of poly(A)
signals at cDNA positions 1846–1851 (ATTAAA) and
3131–3136 (AATAAA). Both transcripts are observed in
different tissues (see below).
We also sequenced and assembled a 1,805-bp Gallus
gallus Nipa2 cDNA, encoding a 361–amino acid pu-
tative polypeptide. Adjacent to the Fugu Nipa1 gene, we
identified the Fugu Nipa2 ortholog, encoding a 366–
amino acid putative polypeptide. There are five coding
exons that correspond to exons 3–7 of the orthologous
human and mouse genes (fig. 3c) with conserved exon-
intron boundaries (table 4), although putative noncod-
ing exons 1 and 2 have yet to be identified in Fugu. The
Fugu Nipa1 and Nipa2 genes were found in conserved
positions with respect to the mouse locus (fig. 1f), and
Fugu orthologs for the p, Herc2, Cyfip1, and Gcp5 genes
were also identified in conserved positions (data not
shown), providing strong evidence that each represents
the ortholog of the mammalian genes. Finally, the po-
sition of the splice donor and acceptor sequences for the
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fourth intron of NIPA2 is conserved in all homologs
analyzed (fig. 3c), including the single intron present in
the insect “ancestral” gene, intron 2 for the “ancestral”
C. elegans gene (total of six exons), and intron 2 of an
Arabidopsis paralog with nine total exons.
Comparison of human NIPA2 and mouse Nipa2
cDNAs demonstrates two peaks of homology, one that
begins at the NIPA2 start codon in exon 3 and the other
that is a short region (∼120 bp) in exon 1 (fig. 3d). The
latter encodes a potential 36-to-40–amino acid upstream
ORF (uORF) that is conserved in mammals (figs. 3d and
3e), and several additional uORFs occur in exons 1–3.
Distantly related uORF sequences also occur in the
NIPA2 5′ region in chicken (where it is the second uORF)
and Xenopus (fig. 3e). A conserved uORF, such as that
observed here in NIPA2 loci, is likely to regulate NIPA2
translation (Morris and Geballe 2000).
Polypeptide and Phylogenetic Analyses of the NIPA1
and NIPA2 Family
Analysis of the human, mouse, chicken, Xenopus, and
Fugu NIPA1 and NIPA2 polypeptide sequences (figs. 4a
and 4b), as well as the ancestral invertebrate and related
plant members (fig. 4b), identified nine hydrophobic seg-
ments in each that likely encode putative transmembrane
helices (TMH) (fig. 4c). Although the TMHMM pro-
gram assigned a lower probability for TMH6 in human
and mouse NIPA1, it is nevertheless clear that there is
a hydrophobic domain of sufficient length to span the
lipid bilayer and that TMH6 is clearly predicted in Fugu
NIPA1, as well as in all related proteins (fig. 4c). We
conclude that the NIPA1 and NIPA2 gene family encode
polypeptides that have nine transmembrane-spanning
helices.
Alignment of amino acid sequences of the NIPA1
polypeptide from human, mouse, and Fugu reveals these
to be highly conserved (fig. 4a; table 5). Indeed, the
human and mouse sequences display 98% identity, with
a single amino acid change other than the length of the
polyalanine tract, whereas NIPA1 in Fugu is ∼55% iden-
tical to that in mammals. Alignment of amino acid se-
quences of the NIPA2 polypeptide from human, mouse,
chicken, Xenopus, and Fugu shows identities ranging
between 78% and 96%, with the C-terminus being the
most divergent (fig. 4b; table 5). Remarkably, NIPA1
and NIPA2 polypeptide sequences are related, with
32%–36% identity (and 47%–50% similarity) between
any paralogous pair within these five species. Similarly,
the ancestral Drosophila, C. elegans, and Anopheles poly-
peptides and a representative Arabidopsis member are
highly related, with 40%–49% identity to vertebrate
NIPA2 and lower identity (29%–34%) to vertebrate
NIPA1 (table 5). The phylogenetic relationships are best
seen in a tree diagram, which clearly illustrates the
grouping of NIPA2 and NIPA1 homologs within ver-
tebrates, and the distant ancestral members in inverte-
brates and Arabidopsis. The phylogenetic distance be-
tween NIPA1 and NIPA2 paralogs is as great as that
between them and ancestral members, strongly suggest-
ing that NIPA1 and NIPA2 have evolved related but
different functions.
Analyses of Imprinting for BP1–BP2 Genes and Mouse
Orthologs
The most proximal known imprinted gene in 15q is
MKRN3, which is located just distal to BP2, although
the presence of replication asynchrony in the pericen-
tromeric region (see the “Introduction”) and at mouse
Nipa1-Nipa2-Cyfip1 (fig. 2c) raises the possibility that
the imprinted domain could extend further. Conse-
quently, we tested whether the four BP1–BP2 region
genes might be imprinted in human, using RNA from
cells from patients with imprinting mutations who have
two maternally (PWS) or two paternally (AS) imprinted
chromosomes 15 (Buiting et al. 1995; Saitoh et al. 1996),
as well as a somatic cell hybrid imprinting assay in which
the rodent cell lines retain either a maternal or a paternal
human chromosome 15 (Gabriel et al. 1998). RT-PCR
shows that human NIPA1 (both the major mRNA de-
tected by a 167-bp band and a larger form with the
alternatively spliced exon 3b), NIPA2, GCP5, and CY-
FIP1 are each expressed in lymphocyte cells from a nor-
mal individual and PWS and AS imprinting mutation
patients (figs. 5a and 5b), whereas SNURF-SNRPN, a
paternally expressed imprinted gene in the PWS region
as a control is only expressed in the normal and AS
individuals (fig. 5a). In addition, CYFIP1 is expressed
from both the maternal and paternal chromosome 15
in somatic cell hybrids (fig. 5b). Therefore, the four BP1–
BP2 genes are nonimprinted in peripheral blood lym-
phocytes and in fibroblasts.
To test imprinting in the mouse, we used a transgenic
PWS and AS mouse model that has a paternally or ma-
ternally derived chromosome 7C deletion, respectively,
spanning at least from Frat3 through Herc2 (Gabriel et
al. 1999; Chai et al. 2001). On the basis of the deletion
of BAC 252P22 (fig. 2b), the 3′ UTR of Cyfip1 and all
of Nipa1 and Nipa2 are included in the deletion (see fig.
1f), as are 5′ Cyfip1 and Gcp5 (J.M.G., J-H.C., and
R.D.N., unpublished data), allowing this model to be
used to test imprinting of these genes. All four genes
(Nipa1, Nipa2, Cyfip1, and Gcp5) are expressed in wild-
type, TgPWS(del), and TgAS(del) mice, resembling the control
Mkrn1 profile (fig. 5c). In contrast, the imprinted Snurf-
Snrpn gene is not expressed in the PWS mouse, as ex-
pected (fig. 5c). Therefore, mouse Nipa1, Nipa2, Cyfip1,
and Gcp5 genes are expressed from both the paternal
and maternal alleles and are nonimprinted in the brain.
Figure 3 Vertebrate Nipa1 and Nipa2 gene structures. a, Schematic genomic structure of NIPA1 in human, mouse and Fugu. Coding
regions (shaded rectangles) and untranslated (5′ UTR and 3′ UTR) regions (open rectangles) are shown. The horizontal black bars are CpG
islands, the arrows below the exons (e) are primers used for RT-PCR, and the vertical dotted lines are functional polyA signals (predicted in
Fugu). Alternative polyadenylation generates two different 3′ ends for human and mouse Nipa1 (with distance between the polyA signals shown).
b, Highly conserved 3′ ends of the mammalian NIPA1 7.5-kb mRNA sequences from five eutherian species, aligned by CLUSTAL W. Black
nucleotides with gray background agree with the consensus, and polyA signals are shown as white letters on black background. GenBank
accession numbers for the NIPA1 3′ ESTs are as follows: human, BF439642; pig, BI339387; cow, BE685351; mouse, BE946294; and rat,
AW533027. c, Genomic structure of orthologous human, mouse, and Fugu NIPA2 genes, as well as conserved intron placement in ancestral
genes from Drosophila and Anopheles. Symbols as for panel a. The shaded box in exon 1 represents uORF1, but putative 5′ noncoding exons
in Fugu (dotted line) have not been identified. d, Conserved ORFs in the 5′ UTR (exons 1–3) of the vertebrate NIPA2 transcripts. White letters
on black background represent sequences conserved in all species shown, black letters with gray background have one mismatch, and the
initiation codons of NIPA2 and uORF1 have bold white letters on black background. Also shown are exon (ex) positions for the mouse (mu)
gene, and the stop (TGA or TAA) codons for the uORF1. GenBank accession numbers for the NIPA2 5′ ESTs are as for fig. 4b,, and the
GenBank accession number for dog is BM538411. Alignments were generated with CLUSTAL W. e, Amino acid sequence of the putative exon
1 uORF1 from human, mouse, cow, dog, chicken (uORF2), and Xenopus NIPA2 mRNAs. White letters on black background represent sequences
conserved by comparison with the mammalian consensus, and black letters with gray background represent sequences conserved in fewer
species, and italics represent chemically similar amino acids. GenBank accession numbers are as for fig. 4b,and the GenBank accession number
for chicken is AJ452290.
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Expression Analyses of BP1–BP2 Genes and Mouse
Orthologs
The tissue patterns of expression for the four BP1–
BP2 region genes and their mouse orthologs were studied
by northern blot analysis. As predicted from cDNA and
genomic analyses (see above), a single 2.4-kb transcript
is seen for human NIPA2 (fig. 6a), whereas 1.9 kb and
3.2 kb transcripts occur for mouse Nipa2 (fig. 6b), with
constitutive expression in both species including pro-
nounced expression in the placenta (figs. 6a and 6b). In
mouse, a 1.9-kb Nipa1 transcript is also constitutive but
at relatively low levels, whereas a larger (7.5-kb) mRNA
is seen in several tissues, with both mRNA isoforms en-
riched in brain (fig. 6b). Similarly, the human NIPA1
locus expresses a short (2.2-kb) and a long (7.5-kb)
mRNA at low levels, with enrichment of the larger iso-
form in neuronal tissues (Rainier et al. 2003 [in this
issue]). Similar studies with CYFIP1 demonstrate a 4.4-
kb constitutively expressed mRNA in human (fig. 6c)
and mouse (fig. 6d), with highest levels in placenta (figs.
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Figure 4 NIPA1 and NIPA2 polypeptides. a, Amino acid alignment of NIPA1 orthologs in human, mouse, and Fugu. White letters with
black background represent identical residues, black letters with light gray shading indicate conserved substitutions. Putative transmembrane
(Tm) domains are designated by brackets, and the positions of exon (e)-intron boundaries are shown. GenBank accession numbers are: human
NIPA1, BK001020; mouse Nipa1, AY098645; and Fugu Nipa1 was predicted from genomic sequence (see the “Material and Methods” section).
c, Amino acid alignment of NIPA2 orthologs from human (GenBank accession number BK001120), mouse (GenBank accession number
BK001121), chicken (GenBank accession number AY099502), Xenopus (GenBank accession number BK001125), Fugu (predicted as for panel
a), ancestral genes from Drosophila (GenBank accession number AE003637), Anopheles (predicted from GenBank accession number
AAAB01008980), C. elegans (GenBank accession number AC006804), and a representative Arabidopsis homolog (GenBank accession number
AY046035). Symbols as for panel a. c, Representative transmembrane helices based on hydrophobicity plots. d, Phylogenetic comparison of
vertebrate NIPA1 and NIPA2 orthologs, ancestral invertebrate homologs and a representative Arabidopsis homolog. The tree was constructed
using CLUSTAL W, and branch lengths are proportional to sequence divergence. Each polypeptide is designated as the species, and the number
1 or 2 designates NIPA1 or NIPA2, respectively, except for ancestral members.
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Table 4
Exon-Intron Structures of NIPA1 and NIPA2 in Human, Mouse, and Fugu
Gene, Exon,
and Species
cDNA
Position
(bp)
Splice Acceptor
Intron Exon
Exon Size
(bp)
Splice Donor
Exon Introna
NIPA1:
1b:
Human 1 5′ UTR  AUG codon 203 AAGCGGCGAGgtagggcgggcg
Mouse 1 5′ UTR  AUG codon 165 AAAAGGCGAGgtagggcgggcc
Fugu 1 5′ UTR  AUG codon 121 CGTGAAAAAGgtagagcacata
2:
Human 204 ctcattttttataagGTACTTCCTA 48 ACAATCGCAAgtaagtagcctg
Mouse 166 cacctttttttatagGTACTTCCTA 48 ACAATTGCAAgtaagtggttta
Fugu 122 atgtgttttccacagGACGTTCGTA 48 ACGTTGTCCAgtgagtacaggg
3:
Human 252 tgattttcttgacagTGGCTGTTGG 91 TACCGTTCGGgtgagagccaag
Mouse 214 tgattctcttgacagTGGCTGTCGG 91 TACCGTTTGGgtgagaactgac
Fugu 170 ctgtgcataaaacagTGGCTGTAGG 91 TCCTATTTGGgtaggtcttaga
3b:
Humanc NA tctgctgtattccagACAGATGCCC 82 AGGCATTAAGgttctgtgacct
4:
Human 343 cttttttcaataaagGTCCATTTTA 161 ACCAACCCAGgtaattcctttc
Mouse 305 tttccttaattgaagGTCCATTTTA 161 ACCAATCCAGgtaactcgttct
Fugu 261 gttgttgacacgcagAGCTCTGCTG 161 CTGGACCCAGgtcagtttgttt
5:
Human 504 ctgtctgtgttccagTGTTTGTGGG 1,744d Stop codon  3′ UTR
Mouse 466 ccatctgtcttgcagTGTTTGTGGG 1,419d Stop codon  3′ UTR
Fugu 422 ttttccaccctgcagTGTTTGTGGC 1511d Stop codon
NIPA2:
1e:
Human 1 5′ UTR 245 GCCGACTAGGgtgaggtcgcca
Mouse 1 5′ UTR 231 CGGCCCTAAGgtagctacttcc
Fugu Unknown
2d:
Human 246 ttttcttctttctagGCTGGAGCTA 136 AAACTTACATgtaagttaaaat
Mouse 232 ttttcttctttccagGGTGGAACTA 121 AAACTTACATgtaagttaaaat
Fugu Unknown
2bc:
Human NA atatctctgttgcagGCTCTCCCGG 122 ATTTTCAAACgtaagtcagaatg
3b:
Human 382 ttttttattgtttagGTTTGAAGAC 232 ATGAGAGCAGgtaggttatgcc
Mouse 353 ttttatatcatttagGTTTGAGGAT 229 ATGAGAGCAGgtaagttatgtc
Fugu 1 AUG codon 139 ATGCGGGCAGgtattcaaccct
4:
Human 614 tttcttcattcacagGTCAAGGTGG 57 CTGCTGTCAAgtatgtataaag
Mouse 582 aatatttcttcacagGTCAAGGAGG 57 CTGCTGTCAAgtatgtatagag
Fugu 140 gttccctcccttcagGCCAGGGCGG 57 CTGCTGTCAAgtaagtctaatt
5:
Human 671 ttgtctgtctctaagTGGGAGCTGG 91 TGCTAGTAAGgtaaggacacgt
Mouse 639 tgttcatctcttcagTGGGAGCCGG 91 TCCTCGTAAGgtaagactctgt
Fugu 198 tatttgtctttacagTGGGGGCGGG 91 TGCTCGTCAGgtactctgctca
6:
Human 762 tcctccccattttagTGCCATTCTT 161 GGTGATCCAGgtaagaaaaaag
Mouse 730 tattcttccttttagTGCCATTCTG 161 GGTGATCCAGgtaagaaaaaac
Fugu 290 taaatgtcactgcagTGCTGTGCTG 161 GTGGATCCAGgtagcgagcggc
7:
Human 923 ctttgcctcctccagGTTTTGTGGT 1,506d Stop codon  3′ UTR
Mouse 881 ctttgcttcctctagGTTTTGTGGT 977d Stop codon  3′ UTR
Fugu 451 ccgtcttctctccagGGTTTTGTGT 1357d Stop codon
a Lowercase letters refer to intron sequences, and uppercase letters refer to exon sequences. Underlined
letters “ag” and “gt” represent consensus splice acceptor and donor sequences, respectively.
b Exon encoding AUG start codon.
c Low level alternatively spliced exon; NA p not applicable.
d First polyA signal (human, mouse) or stop codon (Fugu).
e Noncoding 5′ exon (may encode uORF).
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Figure 5 Imprinting assay of BP1–BP2 genes by RT-PCR in human and mouse. a, NIPA1, NIPA2, and GCP5 mRNA expression was
examined in lymphoblast cell lines derived from a normal individual and from patients who have PWS (PWS-U) and AS (AS-J) with imprinting
defects. An imprinted control gene, SNURF-SNRPN, shows paternal-only expression, as detected in the AS but not the PWS cell line.  p
RT present;  p RT minus control. b, CYFIP1 imprinting analysis in families PWS-U and AS-J with imprinting defects and in somatic cell
hybrids with a single maternal (Mat) or paternal (Pat) human chromosome 15. c, Nipa1, Nipa2, Cyfip1, Gcp5, imprinted control Snurf-Snrpn,
and control Mkrn1 mRNA expression in mouse. Brain mRNA from wild-type (WT), or transgenic-deletion mouse models of PWS (TgPWS) and
AS (TgAS) were used for RT-PCR. Mkrn1 is a nonimprinted control gene from mouse chromosome 6A (Gray et al. 2000). Paired lanes show
reactions with () or without () reverse transcriptase.
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Figure 6 Expression of BP1–BP2 genes in human and mouse tissues. a, Expression of human NIPA2 in various tissues by northern
analysis, with b-ACTIN as a control. b, Constitutive expression of Nipa2 and brain-enriched expression of Nipa1 in mouse tissues by northern
blot analysis, with Gapdh as a control. c, Expression of CYFIP1 in different human tissues and regions of brain, with SNURF-SNRPN or b-
ACTIN as controls. d, Mouse Cyfip1 is widely expressed and enriched in placenta. Gapdh expression serves as a control. e, Human GCP5 is
expressed at high levels in muscle and at lower levels in other tissues. f, Mouse Gcp5 is constitutively expressed in different tissues. In each
case, radioactivity from each blot was stripped prior to successive hybridizations. Bp brain; Cp colon; Clp cerebral cortex; Cmp cerebellum;
F p frontal lobe; H p heart; K p kidney; Leu p peripheral blood leukocyte; Li p liver; Lu p lung; M p medulla; O p occipital lobe; Pa
p pancreas; Plp placenta; Pup putamen; S p spinal cord; Sip small intestine; Smp skeletal muscle; Sp; spleen; Tp testis; Thp thymus;
and Tl p temporal lobe.
6c and 6d) and equal levels throughout the brain (fig.
6c). GCP5 has a 3.7-kb transcript in human (fig. 6e)
and mouse (fig. 6f), with the former enriched in muscle
tissues, whereas a smaller (2.8-kb) GCP5 mRNA is also
seen in some tissues. Mouse Gcp5 is also enriched in
placenta (fig. 6f), as is true for NIPA2 and CYFIP1 in
human and mouse.
Discussion
Chromosome rearrangements involving BP1 or BP2 in
15q11.2 include proximal deletion end points for PWS/
AS deletions (Amos-Landgraf et al. 1999; Christian et
al. 1999), duplications, and triplications (Roberts et al.
2002) and for inverted duplicated chromosomes (inv
dup [15]) (Cheng et al. 1994; Leana-Cox et al. 1994;
Huang et al. 1997). Numerous duplicons mapping to
the BP1, BP2, and BP3 segments appear to be transcribed
pseudogenes, including HERC2 duplicons, a truncated
copy of poly(A)-specific ribonuclease from 16p13,
LCR15 duplicons that include the golgin-like protein
gene and SH3P18 also mapped at 15q24 and 15q26,
and sequences encoding an ATP-binding cassette pro-
tein, a BEM-1/BUDS suppressor-like protein, and MYLE
(Buiting et al. 1999; Amos-Landgraf et al. 1999; Chris-
tian et al. 1999; Ji et al. 1999; Pujana et al. 2001).
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Similarly, only large duplicated and rearranged blocks
of sequences derived from other chromosome locations
have been mapped centromeric of BP1 (Ritchie et al.
1998; Fantes et al. 2002). Here, we have unequivocally
demonstrated that four highly conserved genes (NIPA1,
NIPA2, CYFIP1, and GCP5) are located in a genomic
domain between BP1 and BP2. Our observations have
significant implications for the delineation of the PWS
imprinted domain; for understanding the basis of non-
imprinted genetic diseases that map to this chromosomal
region in human and the homologous chromosome re-
gion in mouse, including modification of the PWS or AS
phenotype; and for an understanding of the fluidity of
the genome during evolution and the way this mirrors
events that occur mechanistically as de novo events in
human disease.
Implications for Genomic Imprinting Mechanisms
All four genes between BP1 and BP2 in 15q11.2 were
shown here to be nonimprinted in lymphoblastoid cell
lines and human-rodent somatic cell hybrids, with the
mouse orthologs nonimprinted in brain. The latter
observation is important because most, if not all, the
imprinted loci in the PWS/AS imprinted domain are
predominantly expressed and imprinted in the brain
(Nicholls and Knepper 2001). We conclude that the
mammalian NIPA1, NIPA2, CYFIP1, and GCP5 genes
are nonimprinted. Although the four mouse genes map
∼2 Mb from the imprinted domain, the human orthologs
are separated from the PWS imprinted domain solely by
BP2 sequences; however, the size of BP2 is poorly defined
because of the complex and incompletely known com-
position of duplicons. Since the HERC2 duplicons
within BP2 include the CpG-rich promoter and are de-
rived from a nonimprinted locus (Amos-Landgraf et al.
1999; Ji et al. 1999), we suggest that one model to ex-
plain the proximal imprint boundary might simply be
the evolutionary integration of “nonimprintable” pro-
moter sequences adjacent to the imprinted domain. In
contrast, when genes such as mammalian MKRN3 and
rodent Frat3 were duplicated by retroposition, they had
promoters that were subject to the imprint process when
these genes integrated into or adjacent to the imprinted
domain (Chai et al. 2001).
Several studies have shown replication asynchrony in
domains with monoallelic gene expression, including
those imprinted (Kitsberg et al. 1993; Chess et al. 1994;
Knoll et al. 1994; Hollander et al. 1998; Simon et al.
1999; Mostoslavsky et al. 2001) and with a transition
from imprinted to nonimprinted sequences at mouse H19,
defined by an asynchronous to synchronous replication
change (Greally et al. 1998). The use of marked mouse
chromosomes 7 gave us an extremely useful tool for
analysis of replication patterns at the Nipa1-Nipa2-Cy-
fip1 domain, where we found asynchrony that was ran-
dom with respect to parental origin. A similar pattern
has been described elsewhere for the P (OCA2) locus in
human 15q13 (Knoll et al. 1994), whereas imprinted
loci replicate the chromosome derived from one parent
(usually the paternal allele) earlier than the other (Kits-
berg et al. 1993; Knoll et al. 1994; Simon et al. 1999).
The OCA2 locus is ∼1.5–2 Mb from the imprinted do-
main, whereas the mouse region studied here is ∼2–2.5
Mb from the mouse 7C imprinted domain. It is possible
that the transition from asynchrony determined by par-
ent of origin to the pattern of random asynchrony that
we have demonstrated here is detectable only with the
use of a marked chromosome such as that used in this
study. Our finding that the four genes in the BP1–BP2
region are nonimprinted suggests that the asynchronous
DNA replication observed proximal to deletion break-
point BP1 (Ritchie et al. 1998) may be another example
of the same phenomenon and does not indicate a more
extensive imprinted domain. Rather, replication asyn-
chrony may identify those chromosomal regions with
the capacity for monoallelic gene expression: however,
we propose that other factors, including DNA methyl-
ation and/or elements of the histone code (Jenuwein and
Allis 2001; Turner 2002), are mechanistically needed to
complete the silencing or activation of individual alleles.
Functional Considerations of a New Gene Family
Two of the four genes identified in the BP1–BP2 region
are the related NIPA1 and NIPA2 genes. Phylogenetic
studies indicate that both paralogous gene members are
ancient and likely arose 450–600 million years ago,
around the time of the origin of vertebrates. Despite the
adjacent chromosome linkage of NIPA1 and NIPA2 and
retention of this syntenic relationship in all examined
vertebrates, there is no evidence that one served as the
precursor to the other. Indeed, four additional NIPA1/
2-related paralogous family members are dispersed in
vertebrate genomes, and each appears to have arisen
early in vertebrate evolution (J-H.C. and R.D.N., un-
published data). Alternatively, NIPA1 or other family
members may be evolutionarily younger, and, after their
origin, they may have gone through a period of rapid
mutation, followed by fixation and a dramatic slow-
down in mutation rate. Further study of this gene family
in extant vertebrate species will shed light on the evo-
lutionary history of this novel gene family.
NIPA1 and NIPA2 differ in gene structure and ex-
pression patterns, reflecting their ancient origins; how-
ever, in both cases, there are five coding exons, and these
show homology in intron placement. In particular, the
only intron in the insect NIPA1/2 gene is conserved in
position in all vertebrate NIPA2, NIPA1, invertebrate,
and plant family members, despite variation in exon
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number. During evolution of NIPA2, two 5′ noncoding
exons arose along with the coding potential for a small
uORF. The presence of one or more uORFs in NIPA2
suggests that this gene undergoes translational regula-
tion (Morris and Geballe 2000) and that translation of
NIPA2 may involve an internal ribosome entry site
mechanism (Fernandez et al. 2002), although further
work will be necessary to examine these possibilities. In
contrast to the constitutive expression of NIPA2 and the
smaller NIPA1 transcript in all tissues of human and
mouse, NIPA1 shows high levels of brain-enriched ex-
pression of a 7.5-kb transcript (as shown here and in
the article by Rainier et al. 2003 [in this issue]). The
mechanism for this may reflect stabilization of the
mRNA in brain for the long form of NIPA1, transcrip-
tional activation plus coordinate polyA site selection in
a neuron-specific manner, or silencing of the latter tran-
scription-polyadenylation pattern in nonneural tissues,
as occurs with the neuron-restrictive silencer factor
(Zhao et al. 1999; Lunyak et al. 2002; Proudfoot et al.
2002; Worthington et al. 2002).
Our prediction of a nine-TMH helix domain structure
for the NIPA1 and NIPA2 polypeptides suggests that
they function as either receptors or transporters. NIPA1/
2 show low homology, spanning three TM domains
(∼29% over ∼93 amino acids), with some G-protein
coupled receptors, such as extracellular calcium recep-
tors and olfactory receptors (data not shown); however,
this may reflect the hydrophobic nature of TM domains,
and any functional or evolutionary relationship remains
conjecture. Indeed, polypeptides with nine TM spanning
passes of the lipid bilayer are rare. Exceptions are glu-
cose-6-phosphatase (Pan et al. 1998), a cardiac Na/-
Ca2 exchanger (Qiu et al. 2001), and the TM9 domain
superfamily (TM9SF) (Chluba-de Tapia et al. 1997);
TM9SF members are localized to endosomes (Schim-
mo¨ller et al. 1998), bind the synthetic ligands cyano-
pindolol and the b-adrenergic agonist SM-11044, and
have roles in colon relaxation and eosinophil chemotaxis
(Sugasawa et al. 2001), or are involved in adhesion and
phagocytosis in Dictyostelium (Cornillon et al. 2000).
However, the TM9SF family is unrelated in primary se-
quence to the NIPA1/2-family. Furthermore, whereas
TM9SF members have a signal peptide (type I topology),
members of the NIPA1/2-family do not, and the latter
must have internal membrane targeting sequences. Con-
sequently, the function of the NIPA1/2 family remains
unknown. Nevertheless, the presence of distinct family
members in vertebrates, invertebrates, plants, and bac-
teria (the present article; J-H.C. and R.D.N., unpub-
lished data) indicates that these conserved polypeptides
are likely to be critical for signaling within or between
cells. Studies with antibodies and with animal models
deficient in or overexpressing these genes, as well as iden-
tification of ligands for these polypeptides, are now nec-
essary to determine their functions.
Implications of BP1–BP2 Region Genes for Hereditary
Disease
Since blocks of duplicated sequences that are impli-
cated in homologous recombination flank the BP1–BP2
region genes, chromosome rearrangements involving the
BP1–BP2 region may lead to dosage imbalance or re-
arrangements of the NIPA1, NIPA2, CYFIP1, and
GCP5 genes. This includes loss of one allele in the larger
class I chromosome deletions in PWS and AS, or gain
of one or two alleles, in 15q11-q13 duplications and
triplications as well as for inv dup (15) marker chro-
mosomes (Knoll et al. 1990; Cheng et al. 1994; Leana-
Cox et al. 1994; Huang et al. 1997; Amos-Landgraf et
al. 1999; Christian et al. 1999; Roberts et al. 2002). On
the basis of the finding of small inv dup (15) marker
chromosomes with the BP1–BP2 region but not the PWS/
AS region in a series of patients with generally normal
phenotypes, Huang et al. (1997) concluded that no genes
in these small markers have clinically relevant dosage
effects. In contrast, recent studies by Butler et al. (2003)
found that PWS subjects with class I deletions (BP1–
BP3) have a more severe phenotype than those with class
II deletions (BP2–BP3), including greater self injurious
behavior, deficits in adaptive behavior (including motor
skills), obsessive-compulsive behavior, and difficulties
with reading, mathematics skills, and visual-motor in-
tegration. These data provide evidence that deletions of
the four genes in the BP1–BP2 region may be associated
with dosage-sensitive behavioral and psychological phe-
notypes. We propose that some individuals may have a
condition with just these types of clinical phenotypes
and a deletion or duplication limited to the BP1–BP2
region due to recombination between duplicated se-
quences within BP1 and BP2. Further study of BP1–BP2
region genes and chromosome rearrangements will de-
termine whether the presence of four highly conserved
genes flanked by unstable DNA sequences can have a
significant phenotypic impact.
A chromosome 15 rearrangement limited to the
unique 250-kb BP1–BP2 region was recently found in a
subject with PWS due to a 15q11-q13 deletion that arose
on the paternally inherited chromosome containing a
familial duplication limited to BP1–BP2 (Butler et al.
2002). Consequently, duplications, deletions, or inver-
sions limited to the BP1–BP2 region may predispose to
subsequent larger rearrangements of proximal 15q. In-
deed, a polymorphic 1.5-Mb inversion within a similar
class of duplicated sequences in chromosome 7q11.23
is associated with susceptibility to deletion of the 1.5-
Mb region in Williams-Beuren syndrome (Osborne et al.
2001). Similarly, inversions of BP2–BP3 were identi-
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Figure 7 Model for evolutionary transposition of BP1–BP2 genes by flanking duplicons. Genes are shown as horizontal arrows or
arrowheads indicating the direction of transcription. Black arrows and white arrowheads represent nonimprinted and imprinted genes, respec-
tively. HERC2 and duplicons (dup) derived from HERC2 are shown as gray arrows or bars when transcriptional direction is unknown. The
rectangle indicates a putative transposition of a four- gene cassette with flanking HERC2-duplicons, in an ancestral primate. See text for further
details. Not shown in this schematic is a cluster of three GABAA receptor genes and ATP10C, located between the UBE3A and P loci in human
and mouse, nor additional duplicons that are interspersed with HERC2 duplicons but that are poorly characterized to date (see Nicholls and
Knepper 2001).
fied in four of six mothers of patients with AS deletion
(Gimelli et al. 2003), which supports the previous finding
of a familial 15q11-q13 inversion in the mother and
father of deletion patients with AS and PWS, respectively
(Clayton-Smith et al. 1993), consistent with the large
inversion being a predisposition allele. Indeed, BP1–BP2
deletions or other rearrangements may be more common
than the PWS/AS deletions, which occur at an overall
frequency of ∼1/10,000 newborns, since the distance be-
tween the putative recombining segments is only a frac-
tion of that of the 4–4.5-Mb PWS/AS deletions.
All four BP1–BP2 region genes are candidates for
dominantly inherited spastic paraplegia, locus 6 (SPG6
[MIM 600363]). SPG6 is characterized by insidiously
progressive lower-extremity spasticity in which axonal
degeneration affects primarily the longest axons in the
CNS and is caused by a mutation within a 7.3-cM seg-
ment spanning the PWS/AS region (Fink at al. 1995).
The finding of obligate recombinants for markers within
the cluster of GABAA receptor genes in distal 15q11-q13
ruled these out (Fink et al. 1996). As a dominant dis-
order, SPG6 is not expected to be associated with im-
printed genes, ruling out most other genes in the PWS/
AS deletion region. Since no functional genes are known
proximal to BP1, the BP1–BP2 region genes, particularly
CYFIP1 and GCP5, became prime candidates. CYFIP1
associates with Rac1 and F-actin (Kobayashi et al.
1998), with Rac1 implicated in regulation of the actin
cytoskeleton, including axon growth, guidance, and
branching (Ng et al. 2002). CYFIP1 also associates with
FMRP (Schenck et al. 2001), the fragile X mental re-
tardation protein, which is implicated in neurite exten-
sion, guidance, and branching (Morales et al. 2002). In
addition, GCP5 encodes a protein that is part of the
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human g-tubulin complex required for microtubule nu-
cleation at the centrosome (Murphy et al. 2001). Mi-
crotubules are critical in axonal transport, and defects
in this process are known in spastic paraplegias (Crosby
and Proukakis 2002). However, although NIPA1 and
NIPA2 are of unknown function, the CNS-specific ex-
pression of NIPA1 made it an attractive and correct
candidate (Rainier et al. 2003 [in this issue]).
Mutation studies of the mouse orthologs of the four
BP1–BP2 region genes will shed light on the potential
phenotypic role of recessive loss-of-function mutations
in these genes. Indeed, a locus required for embryo im-
plantation, l71Rl, was identified just proximal to the
pink-eyed dilution (p) gene on the basis of recessively
inherited deletions of the region (Wu et al. 2000). Ge-
netic complementation and molecular mapping define
the critical interval for l71Rl as a small region between
D7Mit70 and 5′ Herc2 (Wu et al. 2000), to which we
have mapped the mouse Nipa1, Nipa2, Cyfip1, and
Gcp5 genes, making one or more of these four genes
likely candidates for l71Rl. Although the homologous
human chromosome BP1–BP2 region is flanked by un-
stable DNA sequences, as discussed above, the mouse
l71Rl data indicate that it is unlikely that individuals
will exist who are homozygously deleted for the BP1–
BP2 region, since such homozygous deletions would be
predicted to be associated with a failure of the embryo
to implant. Should BP1–BP2 deletions occur in associ-
ation with a normal or mild neurobehavioral phenotype
(see above), their inheritance from each parent might be
associated with early pregnancy loss and thus may rep-
resent an important genetic counseling issue.
Evolutionary Transposition of BP1–BP2 Region Genes
Mirrors Recombination Events in Genomic Disease
We have shown that a block of at least six genes
(OCA2, HERC2, NIPA1, NIPA2, CYFIP1, and GCP5)
are syntenic in human, mouse, and Fugu; however, in
human, the latter four genes have transposed to a site
∼4 Mb away from the OCA2 and HERC2 genes. These
and previously published data allow us to propose a
model for the evolution of human 15q11-q13 (fig. 7).
Mouse and Fugu are representative of the ancestral ver-
tebrate arrangement of these genes (fig. 7). The evolu-
tionarily young imprinted domain was subsequently
added in mammals, adjacent to this ancestral domain
(fig. 7) (Chai et al. 2001; Nicholls and Knepper 2001).
During evolution of an ancestral primate, 25–60 million
years ago (Amos-Landgraf et al. 1999; Christian et al.
1999; Ji et al. 1999; Locke et al. 2001), the HERC2
gene began its evolutionary odyssey, and we propose that
duplications of this gene first formed duplicons flanking
a NIPA1-NIPA2-CYFIP1-GCP5 cassette at a position
equivalent to BP3 (fig. 7). Subsequently, the ∼250-kb
four-gene unique cassette (with all required cis regula-
tory elements) and flanking HERC2 duplicons were
transposed by a duplicon-mediated process in an ances-
tral primate to a site ∼4 Mb away, on the other side of
the imprinted gene domain. Here, the flanking HERC2
duplicons would now have formed the BP1 and BP2
domains, as found in human (fig. 7). This transposition
may have involved HERC2 duplicons directly, as sup-
ported by the location of a HERC2 duplicon in BAC
26F2 immediately adjacent to NIPA1 at BP1 (data not
shown). Alternatively, other duplicons have been added
and interspersed with HERC2 duplicons at unknown
times during primate evolution (Buiting et al. 1999;
Christian et al. 1999; Pujana et al. 2001) and may have
contributed to the genomic transposition. Genomic stud-
ies of primates will help determine the timing of these
events and mechanisms, although secondary rearrange-
ments within and between duplicated sequences in dif-
ferent extant primate species might complicate interpre-
tation of the exact evolutionary events. Nevertheless, it
is clear that an evolutionary genetic instability has been
conferred on this domain by the origin and expansion
of large blocks of duplicated DNA sequences, now mir-
rored by the events that mediate chromosome rearrange-
ments in genomic diseases involving 15q11-q13.
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